Company Overview

Repro Med Systems, Inc. (RMS) is located in Chester, Orange County, NY, approximately 60 miles northwest of New York City. RMS manufactures medical devices used in emergency care, hospital settings, nursing homes, other medical facilities and home care.

Who We Are

 

 

Board of Directors

  • Andrew Sealfon

    President, Chairman of the Board of Directors, Co-Founder

    Andrew Sealfon, President of the company and Chairman of the Board of Directors, co-founded the Company in 1980.  He has held various positions including Chief Financial Officer and Director of Sales. He has been responsible for corporate management and for directing the design, development and sales of the Company’s products. His current work is in the design of infusion peripherals including syringe pumps and subcutaneous administration sets for use with immune globulins. His research has culminated with the widespread use of the Freedom60 Syringe Infusion System for SCIG, and High-Flo RMS Subcutaneous Needle Sets. This research continues to demonstrate that an optimum infusion—both subcutaneous and intravenous—can be greatly influenced by the ancillary equipment.

    Mr. Sealfon is an electrical engineer and inventor and has been granted numerous U.S. patents. As an aerospace engineer, Mr. Sealfon was employed by ITT Federal Laboratories Defense Space Group as a Member of the Technical Staff, and later was a Member of the Research Staff of Riverside Research Institute. Mr. Sealfon is a graduate of Lafayette College and continued his graduate studies at Polytechnic Institute of Brooklyn.

  • Dr. Paul Mark Baker

    Board of Directors Member

    Dr. Paul Mark Baker earned a medical degree from Cornell University Medical College. Dr. Baker is a practicing pediatrician and is attending at the Department of Pediatrics of Orange Regional Medical Center, Middletown, NY, and attending at New York Hospital-Cornell Medical Center in New York City. Dr. Baker assisted the company in the development of the RES-Q-VAC Emergency Medical Suction System. In addition, Dr. Baker has published results of use of the RES-Q-VAC in a letter to Lancet, the medical journal.

  • Arthur J. Radin

    CPA, Board of Directors Member

    Mr. Arthur Radin was appointed as a member of the Board of Directors at the end of January 2015. He started his career at Touche Ross & Co. and has been a partner in public accounting firms for over 50 years. He was with Radin, Glass & Co. from 1998 until January 2015 when he joined Janover LLC. He is a member of the New York State Society of Certified Public Accountants Editorial Board. Mr. Radin received a BA degree from Columbia College and a Masters in Business Administration from New York University.

  • Mark Pastriech

    Board of Directors Member

    Mr. Mark Pastreich is a businessman and a real estate investor and broker. He has served on numerous for-profit and not-for-profit boards. Among his other various real estate holdings, he is presently a partner in Casper Creek LLC, which owns the building leased by the Company.

  • Brad Sealfon

    Board of Directors Member

    Mr. Brad Sealfon joined the Board of Directors in 2013.  Since 2011, Brad has held various roles at RMS Medical Products as to better understand the overall Organization.  His time in Sales, Marketing, Quality and Production exposed him to various facets of RMS Medical Products providing a  unique, well-rounded perspective into the operations of a world class manufacturing Company. In his spare time, Brad founded Stokequest, traveling and consulting with fellow adventurers and outdoor enthusiasts.  Brad was also Head of Partnerships for the app WeShelter with a mission to end street homelessness.  Brad also served on the Board of Directors for the Interactive Museum in Orange County, NY.

     

  • David Anderson

    Board of Directors Member

    Mr. David Anderson was appointed to the Board of Directors on February 26, 2016. Mr. Anderson has been in the medical (device) industry for over 23 years and has held the role of Chief Executive Officer for Sterilox Technologies, Inc., Gentis, Inc. and currently with ORTEQ Ltd/CellCoTec Ltd. He has also served on the board for ACell Inc., (Regenerative Medicine for Woundcare) and Aperion Biologics, (ACL Replacement Technology), as well as served on several advisory committees. Mr. Anderson received a B.S. in Chemical Engineering from Cornell University and attended University of Minnesota for Graduate Studies in Microbiology.

  • Joseph Manko, Jr.

    Board of Directors Member

    Mr. Joseph Manko, Jr. has over 20 years of investment experience, predominately in the asset management, investment banking, private equity and corporate securities markets. From 2005-2010 Mr. Manko was a Partner and Chief Executive Officer of Switzerland-based BZ Fund Management Limited, where he was responsible for corporate finance, private equity investments, three public equity funds and the firm’s Special Situations and Event-Driven strategies. Prior to that, Mr. Manko was a Managing Director with Deutsche Bank in London where he was head of their European and Asian Equity Capital Markets business. He began his investment banking career at Merrill Lynch as a Vice President in Hong Kong.

Quarterly Reports

Fiscal Year 2017

Quarter Ending 05/31/2016

Data File Download PDF Download

Quarter Ending 11/30/2016

Data File Download PDF Download

Year Ending 2/28/17

Data File Download PDF Download

Fiscal Year 2016

Year Ending 02/29/2016

Data File Download PDF Download

Quarter Ending 11/30/2015

Data File Download PDF Download

Quarter Ending 08/31/2015

Data File Download PDF Download

Quarter Ending 05/31/2015

Data File Download PDF Download

FY2015

Year Ending 02/28/2015

Data File Download PDF Download

FY2014

Year Ending 02/28/2014

Data File Download

FY2013

Year ending 02/28/2013

Data File Download

FY2012

Year Ending 02/29/2012

Data File Download

FY2018

Information appearing in our Investors pages may contain forward-looking statements which speak only in the context of the time at which they originally were made and were based upon expectations at that time. We urge users of these pages to review our 10-k and other documents we file with the Securities and Exchange Commission.